Drugs / 13C D-Glucose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06022588 | Mar → Apr 2021 | chronic intestinal vascular insufficiency | Erasmus Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C D-Glucose | “a glucose solution in which all six 12C carbons were replaced by 13C D-Glucose.” NCT06022588 ↗ |
| Modality | Diagnostic / imaging agent | “Isotope labelled-butyrate and glucose breath testing could theoretically quantify mucosal oxygen consumption and thereby detect ischemia” NCT06022588 ↗ |
| Route | Oral | “receiving either oral 13C -butyrate or 13C -glucose” NCT06022588 ↗ |